Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | Sell | RECURSION PHARMACEUTICALS INcl a | $42,401,000 | -12.9% | 3,985,087 | -33.3% | 100.00% | 0.0% |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | New | RECURSION PHARMACEUTICALS INcl a | $48,658,000 | – | 5,977,631 | – | 100.00% | – |
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | Sell | RECURSION PHARMACEUTICALS INcl a | $42,401,000 | -12.9% | 3,985,087 | -33.3% | 100.00% | 0.0% |
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXRX | New | RECURSION PHARMACEUTICALS INcl a | $48,658,000 | – | 5,977,631 | – | 100.00% | – |